Strong Q1 Expected From Cipla
  • WebDesk BTVI
  • Aug 07 2019

Cipla's domestic formulations growth is expected to be muted at 3 to 7% year on year. The company is also expected to maintain its US sales to maintain momentum with ramp-up in Sensipar. Here is Hiral Desai with the Q1 earings preview.